Skip to main content

Pharmacy Technology

  • Fulfilling the need for healthcare-information demand among wired adults, seniors

    WHAT IT MEANS AND WHY IT’S IMPORTANT — This is a next-generation pharmacy solution for the next generation of seniors, who begin celebrating birthday No. 65 with the coming of the New Year at a rate of one every 10 seconds, and that’s for nearly two straight decades.

  • Mintel releases annual consumer packaged goods trend predictions

  • U.S. healthcare system should look to VA as baby boomers turn to Medicare

    WHAT IT MEANS AND WHY IT’S IMPORTANT — That Medicare doesn’t universally cover the use of retail clinics — and even create a structure that encourages their use for certain services — is a key symptom of what is wrong with the U.S. healthcare system.

    THE NEWS: Duane Reade Walk-In Medical Care clinics to accept Medicare. For the full story, click here)

  • PhRMA: Alzheimer’s drug market continues to expand

    WASHINGTON Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report by the main lobby for the pharmaceutical industry.

     

    The Pharmaceutical Research and Manufacturers of America said 98 medicines for dementia, mostly Alzheimer’s, were in clinical trials or under review by the Food and Drug Administration.

     

     

  • Dr Pepper scores with football fans

    PLANO, Texas In line with its football-themed campaign, Dr Pepper has partnered with Electronic Arts to develop "Dr Pepper Football," an interactive computer-based video game.

  • Sanofi-Aventis: Dengue fever vaccine in clinical development

    LYON, France A vaccine for the mosquito-borne illness dengue fever is in the final stages of development, Sanofi-Aventis said Thursday.

     

    Sanofi said the first phase-3 trial of the vaccine was under way in Australia.

     

     

  • Biodel receives complete response letter for Linjeta

    DANBURY, Conn. The Food and Drug Administration has turned down an application for an insulin product made by Biodel, Biodel said.

     

    The drug maker announced that it received a complete response letter from the FDA for Linjeta (human insulin [rDNA origin]) for the treatment of Type 1 and Type 2 diabetes.

     

     

  • BIO, GPhA and Sandoz testify at FDA biosimilars hearing

    SILVER SPRING, Md. The main lobbies for the biotechnology and generic drug industries, and a leading manufacturer of generic drugs, testified Wednesday at a hearing sponsored by the Food and Drug Administration to collect public and industry input on the implementation of the regulatory approval pathway for follow-on biologics included in the healthcare-reform bill.

     

X
This ad will auto-close in 10 seconds